Your browser doesn't support javascript.
loading
Neoadjuvant chemotherapy with FOLFOX4 regimen to treat advanced gastric cancer improves survival without increasing adverse events: a retrospective cohort study from a Chinese center.
Sun, Zhen; Zhu, Rui-Juan; Yang, Gui-Fang; Li, Yan.
Affiliation
  • Sun Z; Department of Oncology, Zhongnan Hospital of Wuhan University, Hubei Key Laboratory of Tumor Biological Behaviors & Hubei Cancer Clinical Study Center, No. 169 Donghu Road, Wuchang District, Wuhan 430071, China.
  • Zhu RJ; Department of Pathology, Zhongnan Hospital of Wuhan University, No. 169 Donghu Road, Wuchang District, Wuhan 430071, China.
  • Yang GF; Department of Pathology, Zhongnan Hospital of Wuhan University, No. 169 Donghu Road, Wuchang District, Wuhan 430071, China.
  • Li Y; Department of Oncology, Zhongnan Hospital of Wuhan University, Hubei Key Laboratory of Tumor Biological Behaviors & Hubei Cancer Clinical Study Center, No. 169 Donghu Road, Wuchang District, Wuhan 430071, China.
ScientificWorldJournal ; 2014: 418694, 2014.
Article in En | MEDLINE | ID: mdl-25136668

Full text: 1 Database: MEDLINE Main subject: Stomach Neoplasms / Antineoplastic Combined Chemotherapy Protocols Type of study: Etiology_studies / Observational_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: ScientificWorldJournal Journal subject: MEDICINA Year: 2014 Type: Article Affiliation country: China

Full text: 1 Database: MEDLINE Main subject: Stomach Neoplasms / Antineoplastic Combined Chemotherapy Protocols Type of study: Etiology_studies / Observational_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: ScientificWorldJournal Journal subject: MEDICINA Year: 2014 Type: Article Affiliation country: China